<乌鸦传媒>REALITY Check: Stricter RBC Transfusion Safe for Anemic MI Patients Restrictive strategy makes sense for clinical outcomes, costs Sep 01, 2020
<乌鸦传媒>Surgery Rates Doubled for High-Risk Prostate Cancer Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
<乌鸦传媒>Demographics Make a Difference in Common Skin Cancers Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<乌鸦传媒>In Lupus, Older Age and Male Sex Raise Cancer Risk Role of most medications, though, not yet clear Aug 21, 2020
<乌鸦传媒>Benign or Malignant? No Way to Tell Radiologically Case shows importance of accurate preop diagnosis Aug 17, 2020
<乌鸦传媒>Lower COVID-19 Risk With ADT for Prostate Cancer Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
<乌鸦传媒>The Great Colonoscopy Positioning Debate: Left or Right? Randomized trial provides some answers Aug 13, 2020
<乌鸦传媒>Which Women Choose Hormones for Surgical Menopause? Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
<乌鸦传媒>Calcineurin Blockers for Eczema: No Cancer Signal in Big Study "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<乌鸦传媒>Chemo-Free Regimen Boosts OS in Mesothelioma Big advantage for nivolumab-ipilimumab in nonepithelioid tumors drives advantage over chemo Aug 09, 2020
<乌鸦传媒>Another ALK Drug Tops Crizotinib in First-Line NSCLC Ensartinib doubled PFS over older standard, with improved CNS activity Aug 08, 2020
<乌鸦传媒>FDA OKs Anti-BCMA Drug for Multiple Myeloma Accelerated approval for belantamab mafodotin after four other therapies Aug 06, 2020
<乌鸦传媒>New Insights Into Radiation-Induced Hair Loss Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<乌鸦传媒>Skin Rashes a Clue to COVID-19 Vascular Disease Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
<乌鸦传媒>Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<乌鸦传媒>Myomectomy Edges Embolization for Uterine Fibroids Better quality of life with surgery, but relative impact on fertility remains unresolved Jul 29, 2020
<乌鸦传媒>Alex Trebek, Harry Reid and Their Pancreatic Cancer Treatment Exploring a 'triangle offense' against the disease Jul 28, 2020
<乌鸦传媒>COVID-19 More Deadly Than Cancer Itself? Highlights from the AACR conference on COVID-19 and cancer Jul 24, 2020
<乌鸦传媒>Survival Effect of pCR Elusive in Breast Cancer 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Jul 23, 2020
<乌鸦传媒>Older Age Should Not Rule Out Chemo in Breast Cancer Patients Providers should consider patient priorities when discussing treatment Jul 17, 2020
<乌鸦传媒>The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<乌鸦传媒>HIV: Don't Quit on Hope, Says 'London Patient' IAC roundtable addresses prospects for cure, now proven to be possible Jul 06, 2020
<乌鸦传媒>Minimal Link Between Eczema and Most Cancers Study finds severe eczema tied to small risk for lymphoma Jun 30, 2020
<乌鸦传媒>Brief Quasi-Fasting Diet Boosts Breast Cancer Chemo Response Randomized trial in neoadjuvant setting Jun 28, 2020
<乌鸦传媒>Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<乌鸦传媒>Worse Blood Cancer Outcomes in Hispanics Diagnosis at earlier age, worse survival, especially for those on U.S.-Mexico border Jun 24, 2020
<乌鸦传媒>Endoscopic Procedure Wins in Early Stomach Cancer In the U.S. and Canada, curative resection high, recurrence low -- and learning curve steep Jun 22, 2020
<乌鸦传媒>Combination Ups Survival in Older AML Patients Frontline venetoclax plus azacitidine adds 5 months to median OS versus azacitidine alone Jun 17, 2020
<乌鸦传媒>Biologic Effective in Light Chain Amyloidosis Anti-CD38 therapy added to conventional regimen boosts PFS in trial Jun 16, 2020
<乌鸦传媒>Keytruda Tops Adcetris in Head-to-Head Hodgkin's Trial Checkpoint inhibitor improved PFS in refractory and transplant-ineligible cases Jun 15, 2020
<乌鸦传媒>New Standard for Relapsed/Refractory Multiple Myeloma? Triplet regimen significantly extended median PFS versus doublet in IKEMA study Jun 15, 2020
<乌鸦传媒>High Marks for CAR T Cells in R/R Myeloma Response rates of 70-100% with BCMA-targeted products for heavily treated disease Jun 03, 2020
<乌鸦传媒>Second Surgery Gets OS Win in Recurrent Ovarian Cancer Survival improved by nearly 8 months with cytoreductive surgery at first relapse Jun 02, 2020
<乌鸦传媒>Early Palliation: Boon for AML Patients on Intensive Chemo Intervention led to marked improvements in QoL, mental distress, end-of-life care Jun 02, 2020
<乌鸦传媒>Pembrolizumab May Help in Triple-Negative Breast Cancer Upfront therapy extends progression-free survival in metastatic disease, study shows Jun 01, 2020
<乌鸦传媒>Surgery for Metastatic Breast Cancer Fails to Boost Overall Survival Cumulative data, though, don't rule out benefit for selected patients with de novo stage IV disease Jun 01, 2020
<乌鸦传媒>Add-On Tucatinib Ups Survival in Breast Cancer With Brain Mets TKI plus trastuzumab-capecitabine reduced risk of death by nearly half Jun 01, 2020
<乌鸦传媒>VRd Still Reigns in Newly Diagnosed Myeloma KRd fails to prove superiority in head-to-head trial Jun 01, 2020
<乌鸦传媒>CAR T-Cell Therapy Impresses in Indolent NHL Overall response rate exceeding 90% with axi-cel in relapsed/refractory setting May 31, 2020
<乌鸦传媒>Oral ADT Slashes Heart Risk in Advanced Prostate Cancer Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
